ArticleScientific reports2026

TMEM92 drives EMT-associated invasiveness, cisplatin resistance, and immune suppression in head and neck squamous cell carcinoma.

Rong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.